| Style | Citing Format |
|---|---|
| MLA | Davoudimonfared E, Taghizadehghehi M. "Cost-Effectiveness Analysis of Low Versus High Dose Colistin in the Treatment of Multi-Drug Resistant Pneumonia: A Comment." International Journal of Clinical Pharmacy, vol. 41, no. 3, 2019, pp. 621-622. |
| APA | Davoudimonfared E, Taghizadehghehi M (2019). Cost-Effectiveness Analysis of Low Versus High Dose Colistin in the Treatment of Multi-Drug Resistant Pneumonia: A Comment. International Journal of Clinical Pharmacy, 41(3), 621-622. |
| Chicago | Davoudimonfared E, Taghizadehghehi M. "Cost-Effectiveness Analysis of Low Versus High Dose Colistin in the Treatment of Multi-Drug Resistant Pneumonia: A Comment." International Journal of Clinical Pharmacy 41, no. 3 (2019): 621-622. |
| Harvard | Davoudimonfared E, Taghizadehghehi M (2019) 'Cost-Effectiveness Analysis of Low Versus High Dose Colistin in the Treatment of Multi-Drug Resistant Pneumonia: A Comment', International Journal of Clinical Pharmacy, 41(3), pp. 621-622. |
| Vancouver | Davoudimonfared E, Taghizadehghehi M. Cost-Effectiveness Analysis of Low Versus High Dose Colistin in the Treatment of Multi-Drug Resistant Pneumonia: A Comment. International Journal of Clinical Pharmacy. 2019;41(3):621-622. |
| BibTex | @article{ author = {Davoudimonfared E and Taghizadehghehi M}, title = {Cost-Effectiveness Analysis of Low Versus High Dose Colistin in the Treatment of Multi-Drug Resistant Pneumonia: A Comment}, journal = {International Journal of Clinical Pharmacy}, volume = {41}, number = {3}, pages = {621-622}, year = {2019} } |
| RIS | TY - JOUR AU - Davoudimonfared E AU - Taghizadehghehi M TI - Cost-Effectiveness Analysis of Low Versus High Dose Colistin in the Treatment of Multi-Drug Resistant Pneumonia: A Comment JO - International Journal of Clinical Pharmacy VL - 41 IS - 3 SP - 621 EP - 622 PY - 2019 ER - |